Visser A, van Andel G. 2003. Psychosocial and educational aspects in prostate cancer patients. Patient Educ Couns 49(3):203–206.


Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ, Meschino WS, Piron CA, Narod SA. 2004. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292(11):1317–1325.

Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw WJ. 2003. Effect of estrogen plus progestin on stroke in postmenopausal women: The Women’s Health Initiative: A randomized trial. JAMA 289(20):2673–2684.

Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. 2004a. ‘Chemobrain’ in breast carcinoma?: A prologue. Cancer 101(3):466–475.

Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. 2004b. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer 100(11):2292–2299.

Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM. 2002. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 137(11):889–903.

Wenzel L, Dogan-Ates A, Habbal R, Berkowitz R, Goldstein DP, Bernstein M, Kluhsman BC, Osann K, Newlands E, Seckl MJ, Hancock B, Cella D. 2005. Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr 34:94–98.

Wenzel LB, Fairclough DL, Brady MJ, Cella D, Garrett KM, Kluhsman BC, Crane LA, Marcus AC. 1999. Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer 86(9):1768–1774.

White RL Jr, Wilke LG. 2004. Update on the NSABP and ACOSOG breast cancer sentinel node trials. Am Surg 70(5):420–424.

Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C. 2003. Colorectal cancer screening and surveillance: Clinical guidelines and rationale—Update based on new evidence. Gastroenterology 124(2):544–560.

Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KI, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR. 2005. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status report 2004. J Clin Oncol 23(3):619–629.

Winn RJ. 2002. Clinical Practice Guidelines and Survivorship. Paper commissioned for the National Cancer Policy Board. Unpublished.

Winn RJ, Botnick WZ. 1997. The NCCN Guideline Program: A conceptual framework. Oncology (Huntingt) 11(11A):25–32.

Wooldridge JE, Link BK. 2003. Post-treatment surveillance of patients with lymphoma treated with curative intent. Semin Oncol 30(3):375–381.

Woolf SH. 1992. Practice guidelines, a new reality in medicine. Methods of developing guidelines. Arch Intern Med 152(5):946–952.

Woolf SH. 2000. Evidence-based medicine and practice guidelines: An overview. Cancer Control 7(4):362–367.

Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. 1999. Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines. BMJ 318(7182):527–530.

Wyatt GE, Desmond KA, Ganz PA, Rowland JH, Ashing-Giwa K, Meyerowitz BE. 1998. Sexual functioning and intimacy in African American and white breast cancer survivors: A descriptive study. Women’s Health 4(4):385–405.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement